This test checks whether a small dose of dexamethasone turns down cortisol the way it should, which can point toward cortisol excess when suppression doesn’t happen.
Cortisol is your body’s built-in “get things done” hormone. It follows a daily rhythm, rises with stress, and shifts with sleep, illness, and certain meds. That’s why a single random cortisol number can feel confusing.
The dexamethasone suppression test is designed to cut through that noise. It adds one controlled piece: a dose of dexamethasone, a lab-made glucocorticoid. After that dose, your body is supposed to dial cortisol down. If cortisol stays up, your care team gets a clue that something may be pushing cortisol higher than it should.
This article breaks down what “suppression” means, why timing matters, what can skew the result, and what usually comes next after you see your cortisol value on a lab portal.
What the test is measuring and why dexamethasone is used
Dexamethasone acts like cortisol at the level of the brain’s control center. In most people, that signal tells the pituitary to reduce ACTH, which then tells the adrenal glands to make less cortisol. The test checks whether that feedback loop still works the way it should.
Clinicians use this test most often as part of an evaluation for cortisol excess, including Cushing’s syndrome. Some versions are also used later in the workup to sort out where the signal is coming from (pituitary vs ectopic sources) when cortisol is clearly high.
MedlinePlus describes the core idea plainly: cortisol secretion should be suppressible after dexamethasone, and patterns can help point toward the cause of excess cortisol. MedlinePlus overview of the dexamethasone suppression test is a solid baseline reference for what the test is and how it’s commonly run.
Who usually gets a dexamethasone suppression test
Most people don’t need a cortisol workup. Testing is more likely when symptoms stack up in a pattern that raises suspicion, or when there’s an incidental adrenal finding that warrants a closer look.
The tricky part is that lots of common issues overlap with cortisol-related symptoms. Weight gain, fatigue, sleep disruption, and blood pressure changes can come from many causes. That’s why good clinicians look for clusters, progression, and context rather than chasing one symptom.
NIDDK notes that diagnosing Cushing’s syndrome can be hard because symptoms overlap with other conditions, and clinicians often use more than one test to confirm a diagnosis. NIDDK’s Cushing’s syndrome diagnosis section lays out the common first-line test options, including the low-dose dexamethasone suppression test.
What “low-dose” and “high-dose” mean in plain terms
You’ll see different versions of DST in lab orders. Two broad buckets matter for most readers:
Low-dose DST
This is the common screening-style approach. The overnight 1 mg test is widely used because it’s simple: take dexamethasone late at night, measure cortisol the next morning. Some clinicians use a longer low-dose format over 48 hours, often with repeated dosing.
High-dose DST
This is not a first pass for most people. It’s more often used after cortisol excess is already on the table and the care team is trying to separate likely sources in ACTH-dependent states. StatPearls summarizes how higher-dose testing can help distinguish pituitary-driven Cushing disease from ectopic ACTH sources by looking for partial or complete suppression with higher doses. NCBI Bookshelf (StatPearls) DST overview also lists the common dosing schedules.
Cortisol levels in a dexamethasone suppression test: what the numbers mean
This is the part most people want: you took dexamethasone, you got a morning cortisol result, and now you want to know if it’s “good” or “bad.”
Start with the central concept: the test is about suppression, not about chasing a single “perfect” cortisol number. Your lab report may show a reference range that’s meant for a standard cortisol draw, not a post-dexamethasone draw. Your clinician is likely using a cut point for suppression that matches the test type, the lab method, and your clinical context.
NIDDK describes the low-dose overnight timing many clinicians use: a low dose around 11:00 p.m., then a morning blood draw around 8 a.m. The expected pattern is that cortisol drops after dexamethasone. Cortisol that doesn’t drop raises suspicion for Cushing’s syndrome. NIDDK’s low-dose DST description spells this out in a patient-friendly way.
Two practical points that change how you read your result:
- Assay differences: cortisol tests vary by method and lab. Some methods run higher or lower at the same true cortisol level.
- Dexamethasone absorption and metabolism: if your body didn’t absorb the dose well, or if a med sped up how fast you clear dexamethasone, cortisol may fail to suppress even if your cortisol system is normal.
How to prep so the result reflects your body, not a preventable mismatch
Preparation varies by protocol, but the theme stays the same: the dose timing and the blood draw timing must line up. A DST is a timing test.
Before the night of the dose, ask the ordering clinician or lab about these details:
- Exact dose time window: many overnight protocols use a late-night dose between 11 p.m. and midnight.
- Exact blood draw window: many protocols target an early morning draw around 8–9 a.m.
- Which meds to pause or keep: don’t stop anything on your own, but do disclose all prescriptions, over-the-counter products, and supplements.
- Work schedule and sleep: night-shift sleep patterns can affect cortisol rhythm and how the result is interpreted.
If you’re using estrogen-containing birth control or hormone therapy, bring it up. Estrogen can raise cortisol-binding proteins and shift total cortisol values in ways that can complicate interpretation. Your clinician may adjust the plan or interpret results with that context in mind.
Common reasons a result can look “off” even when cortisol control is fine
DST is useful, but it’s not magic. False positives happen, especially when something interferes with dexamethasone levels or cortisol measurement.
Interference tends to fall into a few buckets:
- Medication interactions: some drugs speed up dexamethasone metabolism, lowering its level and making suppression less likely.
- Missed or late doses: a dose taken hours late can shift the curve.
- Malabsorption: vomiting, severe diarrhea, or certain GI conditions can reduce absorption.
- Acute illness and sleep disruption: cortisol rises with stress and can blunt suppression patterns.
- Lab method quirks: cross-reactivity and method differences can affect totals.
In more complex cases, clinicians sometimes measure dexamethasone levels alongside cortisol to confirm the medication was present at an expected level during the test window. That step can separate “didn’t suppress” from “didn’t get enough dexamethasone.”
Table 1: Practical checklist for interpreting a DST cortisol value
This table is meant to help you gather the context your clinician uses when reading a DST result.
| Result context item | What to verify | Why it matters |
|---|---|---|
| Test type | Overnight 1 mg vs 48-hour low-dose vs high-dose | Each protocol has different expectations and cut points |
| Dose timing | Exact time dexamethasone was taken | A late dose can change the suppression window |
| Blood draw timing | Exact time cortisol was drawn (target often 8–9 a.m.) | Morning timing aligns with cortisol’s daily rhythm |
| Current meds | List all meds and supplements taken that week | Some speed dexamethasone clearance or affect cortisol binding |
| Estrogen exposure | Birth control pills, patches, rings, hormone therapy | Can shift total cortisol readings via binding proteins |
| Recent illness | Fever, infection, severe pain, recent surgery | Stress hormones can push cortisol up and blur patterns |
| Sleep pattern | Night shift, jet lag, insomnia that week | Cortisol rhythm changes can affect a single morning read |
| Lab method | Ask if the lab uses immunoassay or mass spec methods | Method differences can alter thresholds for suppression |
| Repeat testing plan | Whether a second first-line test is planned | Guidelines often use more than one test for confirmation |
How clinicians decide what to do after an overnight 1 mg test
There’s no single move that fits everyone. Still, a common pattern shows up in practice: clinicians combine your DST result with symptoms, exam findings, and at least one other test with strong diagnostic accuracy.
The Endocrine Society’s guideline resource page lists first-line options such as urine free cortisol, late-night salivary cortisol, and the 1 mg overnight or 2 mg 48-hour dexamethasone suppression tests. Endocrine Society guideline resource on diagnosing Cushing’s syndrome is a useful snapshot of that approach.
So if your DST cortisol isn’t suppressed, your clinician may repeat DST under tighter conditions, add a late-night salivary cortisol test, order a 24-hour urine free cortisol collection, or move to ACTH testing depending on the full picture.
When suppression happens but symptoms still bother you
A suppressed cortisol after dexamethasone can be reassuring, but it doesn’t automatically explain how you feel. Many symptoms that mimic cortisol issues come from thyroid disorders, sleep apnea, medication side effects, insulin resistance, depression-related sleep changes, alcohol-related hormonal shifts, and many other conditions.
If your result suppresses and your clinician agrees cortisol excess is unlikely, the next useful step is often a targeted search for more common causes that fit your history and exam. That path can feel slower, but it often gets you to a fix sooner than chasing a rare endocrine diagnosis.
High-dose DST and what it tries to sort out
If you’re hearing about an 8 mg overnight DST, you’re usually past the first screening stage. The care team is often working in an ACTH-dependent scenario and wants another data point to separate likely sources.
StatPearls notes that in ACTH-dependent Cushing syndrome, high-dose DST can help distinguish a pituitary source (Cushing disease) from an ectopic ACTH source, because pituitary-driven ACTH overproduction may show partial suppression with higher dexamethasone doses. StatPearls discussion of high-dose DST gives protocol-level detail on overnight and 2-day options.
Even here, DST rarely stands alone. Imaging, ACTH levels, and sometimes specialized sampling tests can come into play, depending on how strong the signal is and how consistent results are across tests.
Table 2: Typical next steps based on common DST result patterns
This table describes broad workflow patterns. Your clinician may take a different path based on lab method, risk factors, and symptoms.
| DST pattern | What it may suggest | Common follow-up moves |
|---|---|---|
| Cortisol suppresses as expected | Cortisol excess less likely in the current context | Look for other causes; consider another first-line test if suspicion stays high |
| Cortisol does not suppress | Possible cortisol excess or a test interference issue | Repeat under controlled conditions; add late-night salivary cortisol or urine free cortisol testing |
| Borderline or inconsistent results | Noise from timing, sleep, illness, meds, lab variation | Repeat testing; check medication list; consider dexamethasone level confirmation in select cases |
| High-dose test shows partial suppression | May fit pituitary-driven ACTH patterns | Pair with ACTH testing and pituitary-focused evaluation based on the full workup |
| High-dose test shows no suppression | May fit ectopic ACTH patterns or other non-pituitary sources | Broaden source search with clinician-guided imaging and targeted endocrine testing |
| Clinical picture and tests disagree | Mismatch between symptoms and biochemical data | Re-check test setup, repeat with a different first-line test, reassess medications and sleep patterns |
Safety notes and practical tips for test day
Dexamethasone is commonly used in medicine, and a single low dose is usually well tolerated. Some people feel a bit wired, sleep lighter, or notice mild stomach upset. If you’ve had a prior strong reaction to steroids, flag that to the ordering clinician before the test.
On the morning of the blood draw, try to keep the conditions steady. Avoid a late-night workout and avoid unusual stressors when you can. If you get sick during the test window, tell the lab staff and notify the ordering clinician so they can judge whether to proceed or reschedule.
How to talk about your result with your clinician
Rather than asking “Is my cortisol high,” ask questions that match how DST is designed:
- Did my cortisol suppress for the protocol you ordered?
- Which cut point are you using for suppression with this lab method?
- Do any of my meds change how dexamethasone is metabolized?
- Do you want a second first-line test to confirm the pattern?
- If results stay abnormal, what’s the step-by-step plan from here?
That style of discussion keeps the focus on suppression, protocol fit, and next testing logic, which is where the real clarity tends to show up.
References & Sources
- MedlinePlus Medical Encyclopedia.“Dexamethasone suppression test.”Explains the purpose of DST and how cortisol should respond after dexamethasone.
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).“Cushing’s Syndrome.”Outlines diagnosis steps and describes low-dose DST timing and expected cortisol drop.
- Endocrine Society.“Diagnosis of Cushing’s Syndrome Guideline Resources.”Lists recommended first-line tests, including overnight and longer low-dose DST options.
- NCBI Bookshelf (StatPearls).“Dexamethasone Suppression Test.”Summarizes DST protocols and explains how higher-dose testing can support source differentiation in ACTH-dependent states.